PATH | VRL
Menu

Find resources

Total results with these characteristics: 1323

Topic: Disease/vaccine specific information

Page 5 of 67
The Burden of Respiratory Syncytial Virus Infection in Young Children

This article, published in the New England Journal of Medicine, summarizes population-based rates of hospitalization associated with respiratory syncytial virus (RSV) infection and estimates the rates of RSV-associated outpatient visits as derived …

Author: Hall CB, Weinberg GA, Iwane MK, et al.

Publication date: 2009

Burden of Streptococcus pneumoniae and Haemophilus influenzae Type B Disease in Children in the Era of Conjugate Vaccines: Global, Regional, and National Estimates for 2000-15

This article, published in The Lancet Global Health, provides global, regional, and national disease burden estimates for Streptococcus pneumoniae and Haemophilus influenzae type b (Hib) in children from 2000 to 2015. Using World Health …

Author: Wahl B, O'Brien KL, Greenbaum A, et al.

Publication date: 2018

The Burden of Typhoid Fever in Low- and Middle-Income Countries: A Meta-Regression Approach

This article, published in PLoS Neglected Tropical Diseases, provides an updated model-based estimate of the global burden of typhoid in low- and middle-income countries (LMICs). Model-based estimates were used to offer insights for decision-makers …

Author: Antillón M, Warren JL, Crawford FW, et al.

Publication date: 2017

Burden of Typhoid Fever in Low-Income and Middle-Income Countries: A Systematic, Literature-Based Update With Risk-Factor Adjustment

This article, published in The Lancet Global Health, reports the results of a study that aimed to estimate the burden of typhoid in low- and middle-income countries. The authors found that after adjusting for water-related risk, there was an …

Author: Mogasale V, Maskery B, Ochiai RL, et al.

Publication date: 2014

Business and Cervical Cancer: Opportunities to Save Lives

This document is a five-page brief on cervical cancer prevention. It discusses the growing threat of human papillomavirus (HPV), early detection and screening, and available options for prevention and treatment. It also explores various …

Author: GBCHealth

Publication date: 2013

Can Successful Vaccines Teach Us How to Induce Efficient Protective Immune Responses?

This article, published in Nature Medicine, reviews current successful vaccines and identifies their mechanisms of protection in the hopes of tackling the challenges posed by those infectious targets that have thus far escaped successful …

Author: Lambert PH, Liu M, Siegrist CA

Publication date: 2005

Can We Defeat Meningococcal Disease in Low and Middle Income Countries?

This article, published in Vaccine, discusses the challenges of achieving control of meningococcal disease in low- and middle-income countries. The authors argue that in low-income countries the main challenge is a lack of sufficient epidemiological …

Author: Greenwood B, Chiarot E, MacLennan CA, O'Ryan M

Publication date: 2012

Can We, Should We, Eradicate the Meningococcus?

The authors of this article, published in Vaccine, discuss how the introduction of vaccines against Neisseria meningitidis raises the question of whether disease caused by this obligate human bacterium can be controlled, eliminated, or even …

Author: Maiden MC, Frosch M

Publication date: 2012

The Cascading Burden of Diarrheal Disease: Revealing the Hidden Costs of ETEC and Shigella Diarrhea

This interactive data visualization tool tells the full story behind the global burden of enterotoxigenic Escherichia coli and Shigella, the two leading bacterial causes of diarrhea. The visualization features a new set of global disease burden …

Author: PATH

Publication date: 2016

The Case for Investment in Enterotoxigenic Escherichia coli Vaccines

This market assessment aims to increase the awareness of biotechnology and pharmaceutical companies worldwide about the opportunities and potential markets that exist for low-cost and effective vaccines against enterotoxigenic Escherichia coli …

Author: PATH; BIO Ventures for Global Health

Publication date: 2011

A Case Study Using the United Republic of Tanzania: Costing Nationwide HPV Vaccine Delivery Using the WHO Cervical Cancer Prevention and Control Costing Tool

This article, published in BMC Medicine, reports on a study to determine the cost of establishing a human papillomavirus (HPV) vaccine program that delivers three doses of vaccine to girls at schools via phased national introduction in Tanzania. It …

Author: Hutubessy R, Levin A, Wang S, et al.

Publication date: 2012

Causes of Severe Pneumonia Requiring Hospital Admission in Children Without HIV Infection From Africa and Asia: The PERCH Multi-Country Case-Control Study

This article, published in The Lancet, reports the results of a study to estimate the causes of pneumonia in young African and Asian children. Results indicate that in low- and low-middle-income settings with widespread uptake of Haemophilus …

Author: The Pneumonia Etiology Research for Child Health (PERCH) Study Group

Publication date: 2019

Center for Vaccine Innovation and Access

This web page provides information about the work of PATH’s Center for Vaccine Innovation and Access, which brings together expertise across every stage of vaccine research, development, and introduction to make lifesaving vaccines globally …

Author: PATH

Cervical Cancer Action: 2007 to 2014 . . . and Beyond

This briefing paper highlights Cervical Cancer Action's accomplishments and global milestones, engagements and country support, and plans for future investment. It includes a detailed timeline which spans from 2007 to 2013 and a map of the rapid …

Author: Cervical Cancer Action

Publication date: 2014

Cervical Cancer, Cervical Dysplasia, Genital Warts: The Pathogenesis and Clinical Outcomes of HPV Anogenital Infections

This technical six-minute animation explains what HPV is, shows how it infects human tissue, and how disease progresses. It also provides disease burden information specific to HPV and cervical cancer.

Author: Sanofi Pasteur MSD

Publication date: 2006

Cervical Cancer Prevention Action Planner

This interactive tool is designed for public health officials seeking guidance and resources related to developing evidence-based cervical cancer prevention programs in their countries. It includes video mini-lectures and other films, impact models, …

Author: PATH

Publication date: 2012

Cervical Cancer Prevention and HPV Vaccines

This fact sheet outlines the types of support the GAVI Alliance offers for the introduction of human papillomavirus (HPV) vaccines in eligible countries. It also links to the specific requirements for country applications.

Author: GAVI Alliance

Publication date: 2014

Cervical Cancer Prevention and the Millennium Development Goals

This article, published in the Bulletin of the World Health Organization, explores how scaled-up cervical cancer prevention activities, including introduction of the new HPV vaccines and increased access to precancer screening and treatment, can …

Author: Wittet S, Tsu V

Publication date: 2008

Cervical Cancer Prevention at PATH: Two Decades of Progress Toward a World Free of HPV-Related Cancers

This report describes PATH's key cervical cancer prevention initiatives, which include providing technical assistance with human papillomavirus (HPV) vaccine program strategy and planning to low- and middle-income countries.

Author: PATH

Publication date: 2013

Cervical Cancer Screening and Treatment in Low-Resource Settings: Practical Experience From PATH

From 2006 to 2011, PATH conducted human papillomavirus (HPV) vaccination demonstration projects in India, Peru, Uganda, and Vietnam to provide evidence for decision-making about public-sector introduction of HPV vaccines. This report examines the …

Author: PATH

Publication date: 2013

Page 5 of 67